Spot T1D Early, Act Sooner

Target Audience

The educational design of this activity addresses the needs of primary care, family medicine, internal medicine, and pediatric MDs, NPs, PAs, and nurses responsible for early identification and diagnostic decision-making in patients at risk for type 1 diabetes (T1D).

Program Overview

Primary care physicians and pediatricians are well positioned to identify patients at risk of developing T1D by recognizing early signs and symptoms and testing patients or their first-degree relatives for T1D autoantibodies. If patients test positive for these autoantibodies, they can be referred to an endocrinologist for further evaluation, including assessment of eligibility for teplizumab to slow disease progression. In this interactive activity featuring both videos and transcripts, Dr. Bithika Thompson will address 10 commonly asked questions related to T1D autoantibody testing, staging, diagnosis, and next steps.  

Educational Objectives

After completing this activity, the participant should be better able to:

• Incorporate autoantibody screening into practice for the early diagnosis of T1D
• Review differences in T1D and T2D presentation and screening protocols to accurately diagnose T1D, particularly among adults
• Establish workflow protocols to accurately diagnose patients with T1D, and refer to specialists, as needed

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 0.5 contact hour, including 0.0 pharmacotherapeutic contact hours, is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Certified Diabetes Care and Education Specialists

This continuing education activity was developed by Integritas Communications and its educational partners at Global Education Group. ADCES conducted an independent content review and found the content to be relevant and appropriate for diabetes care and education specialists.

Integritas Contact Information

For more information about the accreditation (ACCME and CDCES credit) of this program, please contact Integritas at info@exchangecme.com.

Global Contact Information

For information about the accreditation (ANCC credit) of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

To receive credit for this activity, participants must successfully pass the posttest with a score of 70% and complete the evaluation.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Conflicts of Interest

Integritas and Global adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integritas are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Bithika M. Thompson, MD: Nothing to disclose

The planners and managers at Integritas and Global have no relevant financial relationships with ineligible companies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas and Global do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.